NCT03948568 2022-09-30
REaCT-RETT
Ottawa Hospital Research Institute
Phase 4 Completed
Clinical Trials
6 trialsNCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT01612871 2018-03-05
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT01127295 2018-03-02
PHACS
Institut Claudius Regaud
Phase 4 Completed
NCT02089854 2016-12-02
AETNBC
Peking Union Medical College Hospital
Phase 4 Unknown
NCT01553903 2013-06-04
OXYTAM
Institut Claudius Regaud
Phase 4 Completed